Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#4665 Prognostic value of systemic inflammatory parameters in neuroendocrine tumour patients treated with peptide receptor radionuclide therapy – Preliminary results

Introduction: PRRT (177Lu-Dotatate) is a therapeutic option for advanced NETs (neuroendocrine tumours). Systemic inflammatory parameters, such as NLR, PLR, SII, and other ratios derived from complete blood counts, are considered prognostic markers in NETs and other malignancies.

Conference:

Presenting Author: Maciejewski A

Authors: Maciejewski A, Komarnicki P, Musiałkiewicz J, Gut P, Ruchała M,

Keywords: neuroendocrine tumour, PRRT, systemic inflammatory parameter, PLR, prognostic biomarker,

#4059 Evaluation of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Systemic Immune–Inflammation Index (SII) as potential biomarkers in patients with sporadic pancreatic neuroendocrine tumors (pNET)

Introduction: Pancreatic neuroendocrine tumors (pNETs) are rare neoplasm in which the investigation of new biomarkers is essential. An elevated Neutrophile to Lymphocyte Ratio (NLR), Platelet to Lymphocyte Ratio (PLR) and Systemic Immune-Inflammation Index (SII) has been proposed as a negative prognostic factor in several neoplasms, but their role in pNET is unclear.

Conference:

Presenting Author: Minotta R

Authors: Minotta R, Liccardi A, Cannavale G, Benevento E, Di Iasi G,

Keywords: pancreatic neuroendocrine tumor, neuroendocrine, cancer, biomarker, inflammation,

#3826 Prognostic value of the neutrophil/lymphocyte ratio (NLR) in advanced, non resectable, progressive pancreatic and midgut NET after combine therapy using Lu-177 DOTATOC and CAPTEM

Introduction: Previous data suggest neutrophil/lymphocyte ratios (NLRs) could be used as prognostic factor in various solid tumors.

Conference:

Presenting Author: Kolasińska-Ćwikła A

Authors: Ćwikła J, Kolasińska-Ćwikła A, Zrajkowska A, Pałucki J, Seklecka N,

Keywords: Neuroendocrine Tumor, Receptor, Somatostatin, CAPTEM radioligand therapy (RLT), Progression-Free Survival, Neutrophil lymphocyte ratio,

#3797 Evaluation of neutrophile to lymphocyte and platelet to lymphocyte ratio in patients with medullary thyroid cancer (MTC)

Introduction: Medullary thyroid cancer (MTC) is a rare neoplasm in which the investigation of new biomarkers is essential. An elevated neutrophile to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) has been proposed as a negative prognostic factor in several neoplasms, but their role in MTC is unclear.

Conference:

Presenting Author:

Authors: Minotta R, Liccardi A, Cannavale G, Benevento E, Modica R,

Keywords: neuroendocrine tumor, biomarker, medullary thyroid carcinoma, mtc, nlr, plr,

#3660 Prognostic value of inflammation-related biomarkers in patients with gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) – A systematic review and meta-analysis

Introduction: Hematological indicators of chronic systemic inflammation are among the most promising biomarkers for GEP-NENs, but their prognostic value remains controversial.

Conference:

Presenting Author: Yu F

Authors: Yu F, Cheng Z, Su F, Chen Y, Tan H,

Keywords: Gastroenteropancreatic neuroendocrine neoplasm, inflammation-related biomarker, prognostic value,